Among these, CASP1 has been shown to be significantly down-regulated in prostate cancer [15, 16] and its genetic restoration reduces the tumorigenic potential by increasing apoptotic sensitivity [27]. This evidence concerns the gene CASP1 and prostate carcinoma.